The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2180

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability ; volume:22 ; number:1 ; day:19 ; month:9 ; year:2022 ; pages:1-10 ; date:12.2022
BMC microbiology ; 22, Heft 1 (19.9.2022), 1-10, 12.2022

Creator: Zhou, Lingling
Lian, Kaiqi
Wang, Mengting
Jing, Xueyi
Zhang, Yuanchen
Cao, Jinling

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12866-022-02621-y

URN: urn:nbn:de:101:1-2022120621073554326057

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhou, Lingling
Lian, Kaiqi
Wang, Mengting
Jing, Xueyi
Zhang, Yuanchen
Cao, Jinling
SpringerLink (Online service)

Other Objects (12)

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Antibakterielle und antivirale Wirkung des human bactericidal permeability increasing protein und hieraus abgeleiteter Peptide

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Related objects

Reset password